ATE233092T1 - Verwendung von oxazolidinonderivate zur behandlung von arthritis - Google Patents
Verwendung von oxazolidinonderivate zur behandlung von arthritisInfo
- Publication number
- ATE233092T1 ATE233092T1 AT98960157T AT98960157T ATE233092T1 AT E233092 T1 ATE233092 T1 AT E233092T1 AT 98960157 T AT98960157 T AT 98960157T AT 98960157 T AT98960157 T AT 98960157T AT E233092 T1 ATE233092 T1 AT E233092T1
- Authority
- AT
- Austria
- Prior art keywords
- treat arthritis
- oxazolidinone derivatives
- oxazolidinone
- arthritis
- psoriasis
- Prior art date
Links
- IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-Oxazolidone Chemical class O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 title abstract 2
- 206010003246 arthritis Diseases 0.000 title abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000004681 Psoriasis Diseases 0.000 abstract 1
- 229940030999 antipsoriatics Drugs 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 238000002512 chemotherapy Methods 0.000 abstract 1
- TYZROVQLWOKYKF-ZDUSSCGKSA-N linezolid Chemical compound O=C1O[C@@H](CNC(=O)C)CN1C(C=C1F)=CC=C1N1CCOCC1 TYZROVQLWOKYKF-ZDUSSCGKSA-N 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000001988 toxicity Effects 0.000 abstract 1
- 231100000419 toxicity Toxicity 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6568997P | 1997-11-18 | 1997-11-18 | |
| US7129798P | 1998-01-16 | 1998-01-16 | |
| US7366298P | 1998-02-04 | 1998-02-04 | |
| US7524798P | 1998-02-19 | 1998-02-19 | |
| US7767298P | 1998-03-12 | 1998-03-12 | |
| PCT/US1998/023233 WO1999025344A1 (en) | 1997-11-18 | 1998-11-10 | Use of oxazolidinone derivatives for treating psoriasis, arthritis and reducing the toxicity of cancer chemotherapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE233092T1 true ATE233092T1 (de) | 2003-03-15 |
Family
ID=27535698
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98960157T ATE233092T1 (de) | 1997-11-18 | 1998-11-10 | Verwendung von oxazolidinonderivate zur behandlung von arthritis |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP1032386B1 (de) |
| JP (1) | JP2001522886A (de) |
| KR (2) | KR100574307B1 (de) |
| CN (2) | CN1546030A (de) |
| AT (1) | ATE233092T1 (de) |
| AU (1) | AU743941B2 (de) |
| BR (1) | BR9815615A (de) |
| CA (1) | CA2303961A1 (de) |
| DE (1) | DE69811717T2 (de) |
| DK (1) | DK1032386T3 (de) |
| ES (1) | ES2193592T3 (de) |
| NZ (1) | NZ504612A (de) |
| PT (1) | PT1032386E (de) |
| SI (1) | SI1032386T1 (de) |
| WO (1) | WO1999025344A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1082323A2 (de) | 1998-06-05 | 2001-03-14 | AstraZeneca UK Limited | Oxazolidinon-derivate, verfahren zu ihrer herstellung und diese derivate enthaltende pharmazeutische zusammensetzungen |
| JP2003529544A (ja) * | 1999-09-13 | 2003-10-07 | インサイト・ビジョン・インコーポレイテッド | 眼感染症の予防たのための局所処置 |
| GB9928568D0 (en) | 1999-12-03 | 2000-02-02 | Zeneca Ltd | Chemical compounds |
| US6451345B1 (en) | 2000-01-20 | 2002-09-17 | Eurand Pharmaceuticals Ltd. | Functional coating of linezolid microcapsules for taste-masking and associated formulation for oral administration |
| GB0009803D0 (en) | 2000-04-25 | 2000-06-07 | Astrazeneca Ab | Chemical compounds |
| IL139975A0 (en) * | 2000-11-29 | 2002-02-10 | Univ Ramot | Anti proliferative drugs |
| WO2005060951A2 (en) * | 2003-12-19 | 2005-07-07 | Bionaut Pharmaceuticals, Inc. | Anti-neoplastic agents, combination therapies and related methods |
| CN107456442A (zh) * | 2016-06-03 | 2017-12-12 | 四川赛卓药业股份有限公司 | 一种噁唑烷酮化合物的亚微乳注射剂及其制备方法和用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0610265B1 (de) * | 1991-11-01 | 1996-12-27 | PHARMACIA & UPJOHN COMPANY | Substituierte aryl- und heteroaryl-phenyloxazolidinone |
| SK283420B6 (sk) * | 1992-05-08 | 2003-07-01 | Pharmacia & Upjohn Company | Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny |
| US5688792A (en) * | 1994-08-16 | 1997-11-18 | Pharmacia & Upjohn Company | Substituted oxazine and thiazine oxazolidinone antimicrobials |
| NZ274966A (en) * | 1993-11-22 | 1998-01-26 | Upjohn Co | Substituted-hydroxyacetyl piperazine phenyl oxazolidinone derivatives, use in pharmaceutical compositions |
-
1998
- 1998-11-10 KR KR1020007005366A patent/KR100574307B1/ko not_active Expired - Fee Related
- 1998-11-10 SI SI9830387T patent/SI1032386T1/xx unknown
- 1998-11-10 WO PCT/US1998/023233 patent/WO1999025344A1/en not_active Ceased
- 1998-11-10 PT PT98960157T patent/PT1032386E/pt unknown
- 1998-11-10 KR KR1020057017426A patent/KR100589545B1/ko not_active Expired - Fee Related
- 1998-11-10 EP EP98960157A patent/EP1032386B1/de not_active Expired - Lifetime
- 1998-11-10 AT AT98960157T patent/ATE233092T1/de not_active IP Right Cessation
- 1998-11-10 DE DE69811717T patent/DE69811717T2/de not_active Expired - Fee Related
- 1998-11-10 AU AU15823/99A patent/AU743941B2/en not_active Ceased
- 1998-11-10 CA CA002303961A patent/CA2303961A1/en not_active Abandoned
- 1998-11-10 ES ES98960157T patent/ES2193592T3/es not_active Expired - Lifetime
- 1998-11-10 NZ NZ504612A patent/NZ504612A/xx unknown
- 1998-11-10 DK DK98960157T patent/DK1032386T3/da active
- 1998-11-10 CN CNA2004100027903A patent/CN1546030A/zh active Pending
- 1998-11-10 BR BR9815615-2A patent/BR9815615A/pt not_active Application Discontinuation
- 1998-11-10 CN CNB988100134A patent/CN1142777C/zh not_active Expired - Fee Related
- 1998-11-10 JP JP2000520777A patent/JP2001522886A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| KR20010032178A (ko) | 2001-04-16 |
| HK1036591A1 (en) | 2002-01-11 |
| JP2001522886A (ja) | 2001-11-20 |
| NZ504612A (en) | 2002-08-28 |
| CA2303961A1 (en) | 1999-05-27 |
| CN1142777C (zh) | 2004-03-24 |
| EP1032386A1 (de) | 2000-09-06 |
| PT1032386E (pt) | 2003-07-31 |
| AU743941B2 (en) | 2002-02-07 |
| KR100589545B1 (ko) | 2006-06-19 |
| AU1582399A (en) | 1999-06-07 |
| SI1032386T1 (en) | 2003-06-30 |
| KR20050100009A (ko) | 2005-10-17 |
| ES2193592T3 (es) | 2003-11-01 |
| DE69811717D1 (de) | 2003-04-03 |
| KR100574307B1 (ko) | 2006-04-27 |
| BR9815615A (pt) | 2000-10-24 |
| CN1546030A (zh) | 2004-11-17 |
| DE69811717T2 (de) | 2003-10-16 |
| CN1299281A (zh) | 2001-06-13 |
| WO1999025344A1 (en) | 1999-05-27 |
| EP1032386B1 (de) | 2003-02-26 |
| DK1032386T3 (da) | 2003-05-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE59409832D1 (de) | Pflaster zur behandlung von nagelmykosen | |
| ATE163545T1 (de) | Verwendung von adamantan-derivaten zur behandlung von tinnitus | |
| BR9502707A (pt) | Composto composição farmacêutica e método para o tratamento de uma afecção | |
| BG106825A (en) | Substituted oxazolidinones and their use in the field of blood coagulation | |
| DE69616376D1 (de) | Verwendung von Tiagabin zur Behandlung von Schlafstörungen | |
| DE50214206D1 (de) | Kombinationstherapie substituierter oxazolidinone | |
| ATE221781T1 (de) | Angiostatische verbindungen und zusammensetzungen zur behandlung des glc1a glaukoms | |
| BG103399A (en) | New heterocycle-substituted benzamides and their application for the treatment of diseases | |
| DK0815087T3 (da) | Trisubstituerede phenylderivater | |
| ATE93138T1 (de) | Verwendung insulin-sensiblisierender wirkstoffe zur behandlung von hypertonie. | |
| ATE255894T1 (de) | Mglur5 antagonisten zur behandlung von schmerzen und angstzuständen | |
| DE69811717D1 (de) | Verwendung von oxazolidinonderivate zur behandlung von arthritis | |
| ATE275919T1 (de) | Verwendung von metall-proteinase-inhibitoren, um das wachstum der haare oder körperhaare zu induzieren und/oder zu stimulieren und/oder den haarausfall zu verlangsamen | |
| FI950403A0 (fi) | Neurosuojaavia yhdisteitä | |
| JO3446B1 (ar) | طريقة لمعالجة الأرق الأولي | |
| DE69917074D1 (de) | Optisch aktives pyridyl-4h-1,2,4-oxadiazinderivat und seine verwendung zur behandlung von gefässkrankheiten | |
| DK1077683T3 (da) | Antidepressiv behandling | |
| DE69633673D1 (de) | Verwendung von Halofuginon zur Herstellung eines Medikaments zur Vorbeugung von Neovaskularisation und zur Behandlung bösartiger Tumore | |
| ATE299021T1 (de) | Verwendung von oxazolidinonderivaten zur behandlung von psoriasis | |
| ATE225181T1 (de) | Verwendung von heparinen niedrigeren molekulargewichtes zur behandlung von hirnödemen | |
| SE9800139D0 (sv) | New use | |
| ATE302009T1 (de) | Ubichinon qn zur behandlung von migräneschmerzen | |
| ATE331523T1 (de) | Statin-therapie zur verbesserung der aufrechterhaltung der kognitiven funktion | |
| DE50105253D1 (de) | Verwendung von n-oleoylethanolamin zur behandlung der schuppenflechte (psoriasis) | |
| DE69635282D1 (de) | Behandlung der exzessiven aggressivität mit olanzapine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1032386 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |